Pentwater Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Pentwater Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-355,000	Closed	-$10.2M	–	180
2018 Q4	$10.2M	Sell	355,000 -145,000	-29%	-$4.12M	0.09%	53
2018 Q3	$13.9M	Hold	500,000	–	–	0.12%	52
2018 Q2	$13.9M	Buy	+500,000	New	+$13.4M	0.1%	59

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Pentwater Capital Management's NXTM Position: Q1 2019 in Review

Pentwater Capital Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 355,000 shares — an estimated $10.2M sold.

Pentwater Capital Management first reported a position in NXTM in Q2 2018 and held it in 3 quarters. The position peaked at $13.9M in Q2 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Pentwater Capital Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Pentwater Capital Management sold 355,000 NxStage Medical Inc. shares in Q1 2019, an estimated $10.2M.
Pentwater Capital Management first reported a position in NxStage Medical Inc. in Q2 2018 and held it in 3 quarters.
Pentwater Capital Management's NxStage Medical Inc. position peaked at $13.9M in Q2 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Pentwater Capital Management's 13F filing for Q1 2019, filed 15 May 2019.